ArticleEuropean journal of nuclear medicine and molecular imaging2022

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.

Marcus Unterrainer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.